About the Product

Description


Sematime 14 Tablet containing Semaglutide 14 mg is a high-strength antidiabetic medicine designed for effective and sustained management of type 2 diabetes. It helps in controlling blood sugar levels, improving insulin activity, and supporting weight management in patients requiring advanced therapy.

Semaglutide works by increasing insulin release when blood glucose levels rise, reducing excess sugar production in the liver, and slowing down digestion. This helps maintain stable blood sugar levels and reduces appetite, supporting better glycemic control.

The formulation provides strong and consistent sugar control along with added metabolic benefits, making it suitable for long-term use in diabetes management. It is widely prescribed for patients who need better control despite ongoing treatment.

With increasing demand for advanced diabetes medicines, this product offers excellent scope in the chronic therapy segment. Its strong doctor preference, growing patient acceptance, and steady market demand make it an ideal option for expanding presence and driving consistent growth in the antidiabetic range.

Some patients may experience nausea, vomiting, diarrhea, decreased appetite, abdominal discomfort, or constipation. These side effects are usually mild and tend to decrease over time. Rarely, serious conditions such as pancreatitis or allergic reactions may occur and require immediate medical attention.

Sematime 14 Tablet is indicated for the management of type 2 diabetes mellitus in adults who require improved glycemic control along with diet and lifestyle modifications. It helps lower blood sugar levels, supports weight reduction, and reduces the risk of long-term complications associated with diabetes when used as part of a comprehensive treatment plan.

This medicine should be used under medical supervision. It is not indicated for type 1 diabetes or diabetic ketoacidosis. Patients with a history of pancreatitis, thyroid disorders, or severe gastrointestinal disease should consult their doctor before use. Regular monitoring of blood glucose levels is recommended.

Store in a cool and dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Semaglutide 14mg Tablet in the PCD pharma franchise market?

Semaglutide 14mg Tablet has strong demand in the diabetology, endocrinology, metabolic health, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced diabetes management portfolios.

Why should medical distributors include Semaglutide 14mg Tablet in their product range?

Medical distributors and agencies can benefit from growing demand for Type 2 diabetes management under specialist medical supervision. Semaglutide 14mg is a GLP-1 receptor agonist used for improving glycemic control in adults with Type 2 diabetes mellitus Helps support blood glucose management as part of a comprehensive treatment plan involving diet and lifestyle modifications The oral tablet formulation offers a convenient alternative to injectable GLP-1 therapies for eligible patients Commonly prescribed by endocrinologists, diabetologists, and physicians managing metabolic disorders Increasing awareness of advanced diabetes therapies has contributed to strong market demand This strengthens a comprehensive diabetes and metabolic care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Semaglutide 14mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong demand in the diabetes care segment, long-term therapy usage, repeat prescriptions, specialist-driven sales, reliable supply chain support, and attractive margins in the chronic care market.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.